Radionuclide imaging scans for prostate cancer detection
Part of Cancer, Kidney & urinary clinical trials.
This study compares two types of special imaging scans (PET/CT scans) to see which one better detects prostate cancer or its recurrence. You would undergo both scans as part of the research to help doctors improve how they find and treat prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been newly diagnosed with prostate cancer, suspected cancer recurrence, or previously treated metastatic (spread) prostate cancer
- You have medical evidence of your condition (such as MRI, CT scan, tumor markers, or biopsy results)
- You are scheduled to have both standard imaging scans (PSMA/FDG PET/CT) and a special research scan (ACP3 PET/CT)
- You are able and willing to give written informed consent (or a parent/legal representative can sign on your behalf)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging agent (68Ga-NYM032) used with PET/CT scans to help doctors better detect prostate cancer before surgery. If you have biopsy-confirmed prostate cancer and are planning to have your prostate removed, this trial may help evaluate whether this new imaging method improves cancer detection.
This trial tests a new PET scan called XACP3 to see if it can find prostate cancer as well as the standard PSMA PET scan. You could help by having both scans to compare them.
This study compares two types of PET/CT scans (using different radioactive tracers) to see which one is better at finding prostate cancer, detecting if it has come back, or spotting spread to other parts of the body. You will get both scans so doctors can compare them directly.
This trial compares two types of PET/CT scans (using different radioactive tracers) to see which is better at finding prostate cancer, tracking its return, or spotting spread. It's for people with prostate cancer or those being checked for recurrence after treatment.
This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.
This trial compares two types of PET scans—one using a new tracer called [18F]F-PSMA-N5 and another using an existing tracer called [68Ga]Ga-PSMA-11—to see which is better at finding prostate cancer, including early signs of recurrence. If you have or are suspected of having prostate cancer, this study may help determine how advanced the disease is.
Hear when a new Prostate Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.